Skip to content
Thursday, November 21, 2024
VRT Pharma
Regulatory and Clinical Strategy Consulting
Search
Search
Home
About Us
Fields and Areas of Specialization
Regulatory Strategy
Quality Assurance Consulting
Project Management
Media
Press Releases
Career
Contact Us
Top Stories
Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25
Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg
US FDA approves Dupixent to treat younger kids with esophageal condition
Main Stories
Press Release
Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25
January 26, 2024
sarat puli
Press Release
Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg
January 26, 2024
sarat puli
Press Release
US FDA approves Dupixent to treat younger kids with esophageal condition
January 26, 2024
sarat puli
Editor's Pick
Press Release
Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25
January 26, 2024
sarat puli
Press Release
Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg
January 26, 2024
sarat puli
Trending Stories
Press Release
Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25
January 26, 2024
sarat puli
Press Release
Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg
January 26, 2024
sarat puli
Popular Stories
Press Release
Healthcare sector advocates for innovation, infrastructure boost, and NCD Focus in Budget 2024-25
January 26, 2024
sarat puli
Press Release
Zydus gets USFDA nod for Gabapentin tablets (once-daily), 300 mg and 600 mg
January 26, 2024
sarat puli
Press Release
US FDA approves Dupixent to treat younger kids with esophageal condition
January 26, 2024
sarat puli